Clinical Trial Update: EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [Phase 1]

View source ↗

Summary

Phase 1 trial studying EZN-3042 with re-induction chemotherapy in children with relapsed acute lymphoblastic leukemia; the study was terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Lymphoblastic Leukemia Child
• Leukemia Lymphoblastic Acute Cell

Drugs mentioned

• EZN-3042 (EZN-3042)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood | Phase 1 | Status: TERMINATED | Results posted: 2019-07-24